Cargando…
The Role of Non-Selective TNF Inhibitors in Demyelinating Events
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Its use in neurological disorders is limited however, due to rare adverse events of demyelination, even in patients wi...
Autores principales: | Kristensen, Line Buch, Lambertsen, Kate Lykke, Nguyen, Nina, Byg, Keld-Erik, Nielsen, Helle H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824660/ https://www.ncbi.nlm.nih.gov/pubmed/33401396 http://dx.doi.org/10.3390/brainsci11010038 |
Ejemplares similares
-
Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
por: Byg, Keld-Erik, et al.
Publicado: (2021) -
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
por: von Linstow, Christian Ulrich, et al.
Publicado: (2021) -
Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke
por: Clausen, Bettina H., et al.
Publicado: (2020) -
Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
por: Ali, Farwa, et al.
Publicado: (2016) -
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)